December 3, 2021
The average discrepancy rate of listed medicines in Japan, or the average gap between their NHI prices and market prices, came to “approximately 7.6%” in September 2021 on a preliminary basis, the Ministry of Health, Labor and Welfare (MHLW) said...read more